Skip to content

The implementation plan of comparative clinical observation on the efficacy of common Chinese drug medicine in the treatment of cancer anemia

The implementation plan of comparative clinical observation on the efficacy of common Chinese drug medicine in the treatment of cancer anemia

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100045257
Enrollment
Unknown
Registered
2021-04-09
Start date
2021-04-09
Completion date
Unknown
Last updated
2021-11-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer anemia

Interventions

Sponsors

Dongzhimen Hospital of Beijing University of traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Diagnosis of digestive tract tumor (esophageal cancer, gastric cancer, colorectal cancer) by imaging or histopathology or cytology; 2.In line with the diagnosis of cancerous anemia, and mild to moderate anemia (mild anemia: male Hgb is 90-120g/L; female Hgb is 90-110g/L; moderate anemia: Hgb is 60-90g/L); Peripheral blood film shows small cell hypochromic anemia (MCV64.44µmol/L (360µg/dl); serum ferritin (SF) 3 months; 7.Have not used Chinese or Western medicine for the treatment of anemia one month before joining the group; 8.Have not used a chemotherapy regimen before entering the group, or have stopped the chemotherapy regimen for at least one month (washout period); 9.Take the test voluntarily, sign or not sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Accompanied by damage to the function of the heart, liver, kidney and other important organs; 2.Pregnant women and mental patients; 3.Failure to use drugs as prescribed; 4.During the treatment, due to severe side effects, the treatment was forced to be interrupted.

Design outcomes

Primary

MeasureTime frame
hemoglobin;Symptom and sign score;

Secondary

MeasureTime frame
White blood cell count;platelet count;Serum iron;Vitamin B12;folic acid;

Countries

China

Contacts

Public ContactTian Shaodan

Dongzhimen Hospital of Beijing University of traditional Chinese Medicine

oliviatsd@126.com+86 13691535572

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026